Hybrid nano-scaffolds loaded with resveratrol and Omega-3 fatty Acids: An innovative antimicrobial strategy against biofilm

It is widely accepted that biofilms associated with body tissues are responsible for many antibiotic treatment failures and contribute to various chronic infections. Therefore, it is critical to create novel approaches to wound treatment. The development of nanocarriers to combat biofilms formation has been an area of much research in recent years. The main aim of this work was to develop hybrid nano-scaffolds composed by nanofibers and liposomes, i.e. large unilamellar vesicles (LUVs), loaded with resveratrol (RSV) and/or omega-3 fatty acids (ω<sub>3</sub>) and to evaluate their capacity to prevent biofilm formation. The studies carried out included the preparation and characterization of LUVs, evaluation of antibiofilm activity for Staphylococcus aureus and Escherichia coli, and cytotoxicity evaluation using fibroblasts. RSV and ω<sub>3</sub> loaded LUVs were effective in inhibiting biofilms formation, resulting in an increased antibiofilm effect (almost 100 %) compared to free RSV and ω<sub>3</sub> (65 % - 96.4 %). The biocompatibility of the LUVs was also confirmed (cell viability above 70 %), and a positive effect on cell proliferation (cell viability above 70 %) was observed after 7 days. The porous structure and random orientation of the produced nanofibers impregnated with LUVs enable the exchange of exudates, gases, and nutrients, while resembling the extracellular matrix of the skin, encouraging cell adhesion and proliferation. The nanofibers are characterized by adequate mechanical properties (elongation at break of 208 ± 9 % and Young's modulus of 50.3 ± 0.3 MPa) and a high surface area to volume ratio, thus increasing the release profile of RSV (94.8 ± 2.6 % of RSV within 30 min), which is advantageous for anti-biofilm activity. The impregnation of nanofibers with LUVs loaded with RSV and/or ω<sub>3</sub> may represent a promising approach for improving wound healing therapies, allowing the control of biofilm formation and even promoting skin regeneration.

Authors

Institutions

Publication Details

Journal
International Journal of Pharmaceutics
Published
2025-05-28
DOI
https://doi.org/10.1016/j.ijpharm.2025.125784
Citations
2
Primary Topic
Antimicrobial agents and applications
Type
article
Field-Weighted Citation Impact
1.87

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hybrid nano-scaffolds loaded with resveratrol and Omega-3 fatty Acids: An innovative antimicrobial strategy against biofilm

Daniela Santos, María Pía Ferraz, Rui Baptista, Carla M. Lopes et al.
2 citations
International Journal of Pharmaceutics
Antimicrobial agents and applications
1.87
article

Hybrid nano-scaffolds loaded with resveratrol and Omega-3 fatty Acids: An innovative antimicrobial strategy against biofilm

Daniela Santos, María Pía Ferraz, Rui Baptista, Carla M. Lopes, Hugo Gonçalves, Fernando J. Monteiro, Marlene Lúcio, José Catita, Ana Pereira, Mariana S. Terroso
article en
2 citations

Abstract

It is widely accepted that biofilms associated with body tissues are responsible for many antibiotic treatment failures and contribute to various chronic infections. Therefore, it is critical to create novel approaches to wound treatment. The development of nanocarriers to combat biofilms formation has been an area of much research in recent years. The main aim of this work was to develop hybrid nano-scaffolds composed by nanofibers and liposomes, i.e. large unilamellar vesicles (LUVs), loaded with resveratrol (RSV) and/or omega-3 fatty acids (ω<sub>3</sub>) and to evaluate their capacity to prevent biofilm formation. The studies carried out included the preparation and characterization of LUVs, evaluation of antibiofilm activity for Staphylococcus aureus and Escherichia coli, and cytotoxicity evaluation using fibroblasts. RSV and ω<sub>3</sub> loaded LUVs were effective in inhibiting biofilms formation, resulting in an increased antibiofilm effect (almost 100 %) compared to free RSV and ω<sub>3</sub> (65 % - 96.4 %). The biocompatibility of the LUVs was also confirmed (cell viability above 70 %), and a positive effect on cell proliferation (cell viability above 70 %) was observed after 7 days. The porous structure and random orientation of the produced nanofibers impregnated with LUVs enable the exchange of exudates, gases, and nutrients, while resembling the extracellular matrix of the skin, encouraging cell adhesion and proliferation. The nanofibers are characterized by adequate mechanical properties (elongation at break of 208 ± 9 % and Young's modulus of 50.3 ± 0.3 MPa) and a high surface area to volume ratio, thus increasing the release profile of RSV (94.8 ± 2.6 % of RSV within 30 min), which is advantageous for anti-biofilm activity. The impregnation of nanofibers with LUVs loaded with RSV and/or ω<sub>3</sub> may represent a promising approach for improving wound healing therapies, allowing the control of biofilm formation and even promoting skin regeneration.

International Journal of PharmaceuticsVol. 680
Fernando Pessoa University (PT), Universidade do Porto (PT), Institute of Mechanical Engineering and Industrial Mangement (PT), Paralab (Portugal) (PT), i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto (PT), University of Minho (PT)
Applied Molecular Biosciences Unit, Fundação para a Ciência e a Tecnologia
Openalex Percentile: Top 15%
Antimicrobial agents and applications
1.87
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.